ReviewClinical and translational science2024

Imetelstat, a novel, first-in-class telomerase inhibitor: Mechanism of action, clinical, and translational science.

Ashley L Lennox et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.